Aziz Mottiwala, Chief Commercial Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 5,186 shares at $22.15 ($115K) on 2021-09-10, disclosed to the SEC on 2021-09-14.
Open-market sale of $115k TARS by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.15 | 2,593 | $57K | 50.0% |
| 2 | $22.15 | 2,593 | $57K | 50.0% |
| Total | $22.15 avg | 5,186 | $115K | 100% |
| Filing → |
| TARS | SELL | 2025-03-20 | $1.0M | — | Filing → |
| TARS | SELL | 2024-03-19 | $292K | — | Filing → |
| TARS | SELL | 2023-07-21 | $48K | — | Filing → |